Candidate: Clinton W. Enos Program: Master of Science in Biology Date: Friday July 15, 2011 Time: 9:00 a.m. Place: George Mason University, Prince William campus Discovery Hall, Room 153 Thesis Chair: Dr. Yuntao Wu
Title: "Point Mutation H89A of the HIV-1 Nef Protein Renders a Moderate Impact on HIV-1 Replication and Infectivity: a Look into the Putative Nef/Pak2 Interaction"
A copy of the thesis is on reserve in the Johnson Center Library, Fairfax campus. The thesis will not be read at the meeting, but should be read in advance.
All members of the George Mason University community are
invited
to
attend.
Abstract:
The human immunodeficiency virus type 1 (HIV-1) Nef protein
is a multifunctional accessory protein believed to be necessary for
HIV-1
pathogenesis and AIDS progression. Among
the putative roles of Nef in HIV-1 infection is the association with an
active
cellular serine/threonine kinase, suggested as being the p21-activated
kinase 2
(PAK2). The PAKs are serine/threonine
kinases that are downstream effectors of Rac and Cdc-42 GTPases. The PAKs have been shown to play critical
roles in many different host-cell functions including proliferation,
survival,
motility and cytoskeleton dynamics. The
function of the Nef/PAK2 interaction in HIV-1 infection is not well
understood. Proposed roles for Nef/PAK2
have been, for the most part, based on data employing the over
expression of
Nef or through the use of Nef mutants that, after subsequent studies,
proved to
have pleiotropic effects. However,
recent studies have established the importance of a hydrophobic binding
surface
proposed to be specific for the association of Nef with PAK2. It was in our interest to uncover and further
define a biological role of the Nef/PAK2 interaction in HIV-1 infection
by
designing a system that reflects physiological parameters and utilizes
Nef
mutants directed at the hydrophobic binding surface. To
approach this problem we first designed a
plasmid that exclusively produces the HIV-1 Nef protein in a
physiologically
relevant amount. The Nef-expression
plasmid, pNLDYSE-Nef,
is a pNL4-3 derived, Rev-independent expression vector that allows for
exclusive expression of Nef under the control of the HIV-1 promoter,
the LTR. pNLDYSE-Nef contains the
necessary splicing sites for Nef expression (A1-D5, A4-D7) and lacks
the HIV-1
packaging signal (Y). This results in physiological basal
expression of Nef protein that, when constructing a virus, will be
packaged
into budding virion particles. pNLDYSE-Nef
can also be used in transfection experiments to observe protein-protein
interactions that are influenced by Nef alone.
Additionally, we designed Nef/PAK2 mutants (F191R, H89A, and
V85S) and
cloned them into the pNL4-3 proviral vector as well as pNLDYSE-Nef. The resulting pNL4-3 Nef-mutant plasmids were
used to generate virus. Infection of
resting and pre-stimulated primary CD4 T lymphocytes with Nef/PAK2
mutant HIV-1
viruses demonstrated a mild phenotype as compared to wild
type virus. Of note,
point mutation H89A of HIV-1 Nef impacted multi-cycle replication in
multiple
donors. Infection of the Rev-dependent
reporter cell line, G11, with wild type
virus, Dnef virus, and NL4-3 Nef-mutant virus
indicates that the Nef/PAK2 interaction is influential on Nef’s ability
to
increase infectivity of HIV-1 virion particles.
Virions lacking a nef gene
were observed to be merely half as infectious as wild type. A similar
phenotype existed for the H89A Nef/PAK2 mutant.
However, it appears that the Nef/PAK2 phenotype, exhibited by
mutation
H89A, is not sustained as long as Dnef. Therefore,
there may be an advantage for Nef/PAK2 at low levels of replication,
however the
phenotype is lost as multiple rounds of replication and infection have
occurred. The nef phenotype for
infectivity enhancement appears to last through multiple rounds of
infection
and is most apparent at lower levels of replication. However,
in a more active cellular state
(spinoculation) replication levels are increased and a gradual
disappearance of
the nef phenotype was observed. Since
Nef has been described as modulating the
actin cytoskeleton in a PAK2-dependent manner, we investigated a role
in the
regulation of the actin binding protein, cofilin. Infection
of the T cell line, CEM-SS, with wild type and nef mutant viruses demonstrated no increase in
phosphorylation
levels of cofilin. Collectively, these
data indicate a moderate phenotype for Nef/PAK2 in HIV-1 infection in vitro. However, ultimately the
proposed association
does not appear to be a requirement for HIV-1 replication.